# Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients

> **NCT00533442** · PHASE2 · COMPLETED · sponsor: **University of Miami** · enrollment: 170 (actual)

## Conditions studied

- Type 1 Diabetes

## Interventions

- **DRUG:** Rapamycin
- **DRUG:** Mycophenolate Mofetil
- **DRUG:** Tacrolimus
- **DRUG:** Steroids

## Key facts

- **NCT ID:** NCT00533442
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-09
- **Primary completion:** 2016-05
- **Final completion:** 2016-05
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2017-07-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00533442

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00533442, "Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00533442. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*